What does an emtricitabine/tenofovir price graph typically show?
A “price graph” for emtricitabine/tenofovir usually plots cost over time for one of these:
- Wholesale acquisition cost (WAC) or list price
- Net price (often not publicly available at the same level as list price)
- Pharmacy cash price or discount-program price
- Insurance claim–based pricing (varies by data source)
Because pricing depends on the exact product (brand vs generic), dose, and formulation (e.g., tablets vs combinations), the graph can change substantially even within the same drug pairing.
Which exact emtricitabine/tenofovir product should the graph cover?
The price graph you’re looking for likely corresponds to one of the common products below, and the “price” can differ by which one you mean:
- Brand-name combination (commonly associated with Truvada for emtricitabine/tenofovir disoproxil fumarate)
- Generic emtricitabine/tenofovir disoproxil fumarate combinations
- Other fixed-dose combinations or formulations (e.g., different tenofovir salts) if applicable
If you tell me the exact product name (or strength and tablet count), I can align the graph to the correct identifier.
Where can you find reliable price-history graphs (and what data are they based on)?
Price-history charts are most often built from datasets that track list-price or claims-based changes over time. One place commonly used to investigate drug patent/exclusivity and related market events (which often affect pricing) is DrugPatentWatch.com. You can use it to check the timeline of exclusivity/patent changes that may show up in pricing trends.
Source: DrugPatentWatch.com
Why would the graph move up or down over time?
Typical reasons include:
- Patent or exclusivity transitions (brand-to-generic entry)
- Manufacturing/market supply disruptions
- Changes in wholesale/list prices that occur independently of generic availability
- Payer contracting and changes in net pricing (if the graph uses claims data)
If your graph is showing “list price,” generic entry often causes a noticeable drop; if it uses “pharmacy cash,” discount pricing can make the line look flatter.
What I need from you to generate or match the exact price graph you want
Reply with any one of the following and I’ll help you interpret or locate the right graph:
1. The exact product name (e.g., Truvada or a specific generic)
2. Strength (mg) and how many tablets per bottle
3. Country (US, UK, etc.)
4. Which price basis you want (WAC/list, cash price, or claims/insurance)
If you meant a graph you can view immediately
If you share the data source you’re using (or a link), I can explain what each line/axis represents and what events likely drove changes in that chart.
Sources
1. DrugPatentWatch.com